Mengyao Li
Tianjin, 301617, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ligustilide alleviates myocardial infarction by targeting S100A9 to inhibit neutrophil activation and attenuate the inflammatory cascade.
Journal: Journal of ethnopharmacology
Published: March 16, 2026
Suxiao Jiuxin Pill Promotes Post-Myocardial Infarction Cardiac Repair by Enhancing Regulatory T Cell Function via the ST2L Signaling Pathway.
Journal: Journal of inflammation research
Published: August 01, 2025
Paeoniflorin Attenuates Limb Ischemia by Promoting Angiogenesis Through ERα/ROCK-2 Pathway.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 19, 2025
Danshensu prevents thrombosis by inhibiting platelet activation via SIRT1/ROS/mtDNA pathways without increasing bleeding risk.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 09, 2022
Shuxuetong injection and its peptides enhance angiogenesis after hindlimb ischemia by activating the MYPT1/LIMK1/Cofilin pathway.
Journal: Journal of ethnopharmacology
Published: January 12, 2022
Naoxintong capsule limits myocardial infarct expansion by inhibiting platelet activation through the ERK5 pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 04, 2021
Tetrandrine promotes angiogenesis via transcriptional regulation of VEGF-A.
Journal: Vascular pharmacology
Published: June 20, 2021
Oroxylin a Attenuates Limb Ischemia by Promoting Angiogenesis via Modulation of Endothelial Cell Migration.
Journal: Frontiers in pharmacology
Published: May 05, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026